Anti-Hu Galectin-9 PE

*Chen Z, Dong D, Zhu Y, Pang N, Ding J: The role of Tim-3/Galectin-9 pathway in T-cell function and prognosis of patients with human papilloma virus-associated cervical carcinoma. FASEB J. 2021 Mar;35 (3) :e21401., URL: https://pubmed.ncbi.nlm.nih.gov/33559190/, *Motamedi M, Shahbaz S, Fu L, Dunsmore G, Xu L, Harrington R, Houston S, Elahi S: Galectin-9 expression defines a subpopulation of NK cells with impaired cytotoxic effector molecules but enhanced IFN-γ production, dichotomous to TIGIT, in HIV-1 infection. Immunohorizons. 2019 Nov 15;3 (11) :531-546. , URL: https://pubmed.ncbi.nlm.nih.gov/31732662/, *Bertino P, Premeaux TA, Fujita T, Haun BK, Marciel MP, Hoffmann FW, Garcia A, Yiang H, Pastorino S, Carbone M, Niki T, Berestecky J, Hoffmann PR, Novu LC: Targeting the C-terminus of galectin-9 induces mesothelioma apoptosis and M2 macrophage depletion. Oncoimmunology 2019 Apr 17;8 (8) :1601482., URL: https://pubmed.ncbi.nlm.nih.gov/31413910/, *Klibi J, Niki T, Riedel A, Pioche-Durieu C, Souquere S, Rubinstein E, Le Moulec S, Guigay J, Hirashima M, Guemira F, Adhikary D, Mautner J, Busson P: Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood 2009 Feb 26;113 (9) :1957-66. , URL: https://pubmed.ncbi.nlm.nih.gov/19005181/, *Lhuillier C, Barjon C, Baloche V, Niki T, Gelin A, Mustapha R, Claër L, Hoos S, Chiba Y, Ueno M, Hirashima M, Wei M, Morales O, Raynal B, Delhem N, Dellis O, Busson P: Characterization of neutralizing antibodies reacting with the 213-224 amino-acid segment of human galectin-9. PLoS One 2018 Sep 11;13 (9) :e0202512., URL: https://pubmed.ncbi.nlm.nih.gov/30204750/

The mouse monoclonal antibody 9M1-3 recognizes an epitope within C terminus of human galectin-9, a glycan-binding protein expressed mainly on activated Th cells and FoxP3+ Treg cells.